Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × pazopanib × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 46 Sarcoma 21 Neoplasms 18 Neoplasm Metastasis 15 Ovarian Neoplasms 12 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Recurrence 5 Melanoma 5 Fallopian Tube Neoplasms 5 Thyroid Neoplasms 4 Prostatic Neoplasms 4 Liposarcoma 4 Hemangiosarcoma 4 Urinary Bladder Neoplasms 3 Solid Tumors 3 Lung Neoplasms 3 Leiomyosarcoma 3 Kidney Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Ovarian Epithelial 3 Thyroid Carcinoma, Anaplastic 2 Sarcoma, Synovial 2 Refractory Solid Tumors 2 Neuroendocrine Tumors 2 Gliosarcoma 2 Financial Stress 2 Chondrosarcoma, Extraskeletal Myxoid 2

Interventions

Temozolomide 87 Bevacizumab 49 Radiotherapy 36 Irinotecan 22 Magnetic Resonance Spectroscopy 18 Surgical Procedures, Operative 17 Carboplatin 17 Carmustine 15 Radiation 12 Nivolumab 11 IL13-PE38 8 Erlotinib Hydrochloride 8 Thalidomide 7 Radiotherapy, Intensity-Modulated 7 Lomustine 7 Imatinib Mesylate 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 O(6)-benzylguanine 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 temsirolimus 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Flucytosine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00350727 2013-04-19

VEG102857

GlaxoSmithKline

Phase 2 Completed

75 enrolled 45 charts

Glioblastoma, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡